REVERE

LIVE

Serial Number

97861964

Owner

Revere Pharmaceuticals, Inc.

Attorney

John V. Hobgood, Esquire

Filing Date

Mar 28, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

REVERE Trademark

Serial Number: 97861964

REVERE is a trademark filed by Revere Pharmaceuticals, Inc. on March 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Revere Pharmaceuticals, Inc. (3 trademarks)

36 Orvis Road
Arlington, MA 02474

Entity Type: 03

Legal Representation

Attorney of Record

John V. Hobgood, Esquire

1,013 trademarks filed View all →

Correspondence Address

John V. Hobgood, Esquire WILMER CUTLER PICKERING HALE AND DORR LLP

60 STATE STREET

BOSTON, MA 02109

United States

Trademark Details

Filing Date

March 28, 2023

Registration Date

Not Registered

Published for Opposition

January 14, 2025

Goods & Services

Pharmaceutical preparations for the treatment oncological diseases and conditions, kidney diseases and conditions, inflammatory diseases and conditions and central nervous system diseases and conditions

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2026 EXRA

SOU EXTENSION 2 GRANTED

Mar 12, 2026 EX2G

SOU EXTENSION 2 FILED

Mar 11, 2026 EXT2

SOU TEAS EXTENSION RECEIVED

Mar 11, 2026 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 12, 2025 EXRA

SOU EXTENSION 1 GRANTED

Sep 11, 2025 EX1G

SOU EXTENSION 1 FILED

Sep 11, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Sep 11, 2025 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 11, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 14, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jan 14, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 8, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 19, 2024 CNSA

CORRESPONDENCE E-MAILED

Mar 13, 2024 GRML

SUSPENSION LETTER WRITTEN

Mar 13, 2024 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 13, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 23, 2023 GNRN

NON-FINAL ACTION E-MAILED

Dec 23, 2023 GNRT

NON-FINAL ACTION WRITTEN

Dec 23, 2023 CNRT

ASSIGNED TO EXAMINER

Dec 21, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 20, 2023 NWOS

NEW APPLICATION ENTERED

Mar 31, 2023 NWAP

Related Trademarks

More from this Owner

Serial #97861962

REVERE PHARMACEUTICALS

More in Same Class

STEM CELL MENTORING

BPG BIO

REVERE PHARMACEUTICALS

SORBACT TECHNOLOGY

MAXACTIVE MAXMINERALS

NORTHE STAR